| 1. |
Mochizuki M, Smith JR, Takase H, et al. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis[J]. Br J Ophthalmol, 2019, 103(10): 1418-1422. DOI: 10.1136/bjophthalmol-2018-313356.
|
| 2. |
中華醫學會呼吸病學分會間質性肺疾病學組, 中國醫師協會呼吸醫師分會間質性肺疾病工作委員會. 中國肺結節病診斷和治療專家共識[J]. 中華結核和呼吸雜志, 2019, 42(9): 685-693. DOI: 10.3760/cma.j.issn.1001-0939.2019.09.007.Interstitial Lung Disease Group, Chinese Thoracic Society, Working Committee of Interstitial Lung Disease, Chinese College of Respiratory Physicians. Chinese consensus statement on the diagnosis and treatment of pulmonary sarcoidosis[J]. Chin J Tuberc Respir Dis, 2019, 42(9): 685-693. DOI: 10.3760/cma.j.issn.1001-0939.2019.09.007.
|
| 3. |
Lee SY, Lee HG, Kim DS, et al. Ocular sarcoidosis in a Korean population[J]. J Korean Med Sci, 2009, 24(3): 413-419. DOI: 10.3346/jkms.2009.24.3.413.
|
| 4. |
Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for sarcoidosis-associated uveitis[J]. Am J Ophthalmol, 2021, 228: 220-230. DOI: 10.1016/j.ajo.2021.03.047.
|
| 5. |
Chung YM, Lin YC, Liu YT, et al. Uveitis with biopsy-proven sarcoidosis in Chinese--a study of 60 patients in a uveitis clinic over a period of 20 years[J]. J Chin Med Assoc, 2007, 70(11): 492-496. DOI: 10.1016/S1726-4901(08)70047-9.
|
| 6. |
楊培增, 譚涵丹, 葉子, 等. 結節病性葡萄膜炎的臨床特征分析[J]. 中華眼科雜志, 2023, 59(3): 196-201. DOI: 10.3760/cma.j.cn112142-20220801-00375.Yang PZ, Tan HD, Ye Z, et al. Analysis on the clinical features of sarcoid uveitis[J]. Chin J Ophthalmol, 2023, 59(3): 196-201. DOI: 10. 3760/cma.j.cn112142-20220801-00375.
|
| 7. |
Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and detection of sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline[J/OL]. Am J Respir Crit Care Med, 2020, 201(8): e26-e51[2020-04-15]. https://pubmed.ncbi.nlm.nih.gov/32293205/. DOI: 10.1164/rccm.202002-0251ST.
|
| 8. |
曹緒勝, 王紅, 彭曉燕. 經組織病理學檢查確診的結節病葡萄膜炎的臨床特征[J]. 中華醫學雜志, 2020, 100(32): 2498-2502. DOI: 10. 3760/cma.j.cn112137-20200426-01323.Cao XS, Wang H, Peng XY. Clinical characteristics of patients with biopsy-proven sarcoid uveitis[J]. Natl Med J China, 2020, 100(32): 2498-2502. DOI: 10.3760/cma.j.cn112137-20200426-01323.
|
| 9. |
Ozdal PC, Berker N, Tugal-Tutkun I. Pars planitis: epidemiology, clinical characteristics, management and visual prognosis[J]. J Ophthalmic Vis Res, 2015, 10(4): 469-480. DOI: 10.4103/2008-322X.176897.
|
| 10. |
Prze?dziecka-Do?yk J, W?grzyn A, Turno-Kr?cicka A, et al. Immunopathogenic background of pars planitis[J]. Arch Immunol Ther Exp (Warsz), 2016, 64(2): 127-137. DOI: 10.1007/s00005-015-0361-y.
|
| 11. |
Abu El-Asrar AM, Geboes K. An immunohistochemical study of the ‘‘snowbank’’ in a case of pars planiti[J]. Ocul Immunol Inflamm, 2002, 10(2): 117-123. DOI: 10.1076/ocii.10.2.117.13980.
|
| 12. |
Lardenoye CW, Van der Lelij A, de Loos WS, et al. Peripheral multifocal chorioretinitis: a distinct clinical entity?[J]. Ophthalmology. 1997, 104(11): 1820-1826. DOI: 10.1016/s0161-6420(97)30021-9.
|
| 13. |
Marchese A, Miserocchi E, Giuffrè C, et al. Aurora borealis and string of pearls in vitreoretinal lymphoma: patterns of vitreous haze[J]. Br J Ophthalmol, 2019, 103(11): 1656-1659. doi: 10.1136/bjophthalmol-2018-313491.
|